Morpheahttps://en.wikipedia.org/wiki/Morphea
Morphea is a form of scleroderma that hardens the skin on the face, hands, feet, or any other part of the body, without involvement of internal organs. It involves thickening and hardening of the skin and subcutaneous tissues due to excessive collagen deposition. Morphea differs from systemic sclerosis by the absence of internal organ involvement.

Morphea is a very rare disease. Because of the composition of the photo, the algorithm may have mistaken it for morphea.

☆ In the 2022 Stiftung Warentest results from Germany, consumer satisfaction with ModelDerm was only slightly lower than with paid telemedicine consultations.
  • The lesion of Morphea usually appears as an atrophic pigmented patch.
  • Frontal linear scleroderma
  • Frontal linear scleroderma
  • A black‑and‑white lesion with thinning (or fading) is suspicious for Morphea.
References Localized scleroderma: clinical spectrum and therapeutic update 25672301 
NIH
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
 Upcoming treatments for morphea 34272836 
NIH
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.